Hunter syndrome laboratory findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Irfan Dotani (talk | contribs) No edit summary |
||
| (4 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Hunter syndrome}} | {{Hunter syndrome}} | ||
{{CMG}} | {{CMG}}; {{AE}} | ||
==Overview== | |||
A definitive diagnosis of Hunter syndrome is made by measuring I2S activity in [[serum]], [[white blood cell]]s, or [[fibroblast]]s from skin [[biopsy]]. In some people with Hunter syndrome, analysis of the I2S gene can determine clinical severity. [[Prenatal]] diagnosis is routinely available by measuring I2S enzymatic activity in [[amniotic fluid]] or in chorionic villus tissue. | |||
==Laboratory Findings== | ==Laboratory Findings== | ||
==References== | ==References== | ||
{{Reflist|2}} | |||
[[Category:Needs content]] | |||
[[Category:Cardiology]] | |||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Hepatology]] | |||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
[[Category:Pediatrics]] | |||
{{WS}} | |||
{{WH}} | |||
Latest revision as of 14:15, 19 July 2016
|
Hunter syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hunter syndrome laboratory findings On the Web |
|
American Roentgen Ray Society Images of Hunter syndrome laboratory findings |
|
Risk calculators and risk factors for Hunter syndrome laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
A definitive diagnosis of Hunter syndrome is made by measuring I2S activity in serum, white blood cells, or fibroblasts from skin biopsy. In some people with Hunter syndrome, analysis of the I2S gene can determine clinical severity. Prenatal diagnosis is routinely available by measuring I2S enzymatic activity in amniotic fluid or in chorionic villus tissue.